iCrowdNewswire   Nov 5, 202011:00 AM ET

The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the growth of the extracellular matrix market.

The global extracellular matrix market accounted to US$ 24.30 Mn in 2018 and is expected to grow at a CAGR of 8.2% during the forecast period 2019 – 2027, to account to US$ 47.46Mn by 2027.

Get sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004925/

Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the medical devices. The growth is driven by that countries such as China, Japan, and India which are engaged in conducting several studies. For instance, Australia is also involved in the several studies and also it has held various conferences for the tissue engineering and other application of the extracellular matrix.

Company Profiles

  • Admedus
  • Coloplast Group
  • Merck KGaA
  • Smith & Nephew
  • MTF Biologics
  • Lattice Biologics Ltd.
  • Medtronic
  • Aziyo Biologics, Inc.
  • DSM Biomedical

The studies for the molecular cell biology of extracellular matrix (ECM) are being conducted across the world. The cell adhesion molecules (CAMs), other properties and advantages of the extracellular matrix are turning out to be beneficial area of discovery with several interesting factors for disease and disorders in animals and humans. These advantages are also include treating of some cancers such as breast cancer, pancreatic cancer, liver cancer and colon cancer.

In addition, obesity is coupled with increasing severity of diagnoses for several types of cancer. Also there have been collective evidences that have shown mechanism that enables obese cells or tissue to serve as an extracellular matrix for the cancer progression. However, extracellular matrix holds vital responsibilities in facilitating the proper development and homeostasis of tissues. The extracellular matrix can also govern both normal and cancer cell function and fate. For instance, studies have proven that extracellular matrix isolated from virgin rat mammary glands has been shown to exert antitumorigenic effects on breast cancer cells. Also extracellular matrix isolated from involuting rat mammary glands inhibits the growth of tumorous cells. On the other hand, the protumorigenic effects of the latter are mediated by a mechanism of inflammatory signaling that can be inhibited by nonsteroidal anti-inflammatory drugs.

Extracellular Matrix – MARKET SEGMENTATION

 By Application

  • Vascular Repair and Reconstruction
  • Dural Repair
  • Wound Healing
  • Cardiac Repair
  • Pericardial Repair
  • Soft Tissue Repair

By Raw Material

  • Bovine
  • Porcine
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

Buy this report at https://www.theinsightpartners.com/buy/TIPRE00004925/

Contact Information:

Contact Us:
Call: +1-646-491-9876
Email: [email protected]


Keywords:    Extracellular Matrix Market, Extracellular Matrix, Extracellular Matrix Industry, Extracellular Matrix Market size, Extracellular Matrix Market share, Extracellular Matrix Market demand, Extracellular Matrix Market growth